Protein O-GlcNAc modulates motility-associated signaling intermediates in neutrophils

被引:64
作者
Kneass, ZT [1 ]
Marchase, RB [1 ]
机构
[1] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA
关键词
D O I
10.1074/jbc.M414066200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The modification of serine/threonine residues on cytoplasmic and nuclear proteins by N-acetylglucosamine (O-GlcNAc) is suggested to play a role in the regulation of a variety of signal transduction pathways. We have previously shown that glucosamine (GlcNH(2)), a metabolic precursor of O-GlcNAcylation, increases O-GlcNAc and enhances motility in neutrophils. Here, we extend this correlation by showing that a mechanistically distinct means of increasing O-GlcNAc, achieved by inhibition of O-GlcNAc removal with O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate (PUGNAc), increases basal cellular motility and directional migration induced by the chemoattractant formyl-methionine-leucine-phenylalanine ( fMLP). Furthermore, we demonstrate that O- GlcNAc modulates the activities of signaling intermediates known to regulate neutrophil movement. GlcNH(2) and PUGNAc increase both the basal and fMLP-induced activity of a central mediator of cellular motility, the small GTPase Rac. Phosphoinositide 3-kinase, an important regulator of Rac activity and neutrophil motility, is shown to regulate the signaling pathway on which GlcNH(2) and PUGNAc act. Rac is an important upstream regulatory element in p38 and p44/42 mitogen-activated protein kinase ( MAPK) signaling in neutrophils, and these MAPKs are implicated in chemotactic signal transduction. We show that GlcNH(2) and PUGNAc treatment increases p42/44 and p38 MAPK activities and that these increases are associated with activation of upstream MAPK kinases. These data indicate that O-GlcNAcylation is an important signaling element in neutrophils that modulates the activities of several critical signaling intermediates involved in the regulation of cellular movement.
引用
收藏
页码:14579 / 14585
页数:7
相关论文
共 86 条
[1]   Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic β-cells [J].
Andreozzi, F ;
D'Alessandris, C ;
Federici, M ;
Laratta, E ;
Del Guerra, S ;
Del Prato, S ;
Marchetti, P ;
Lauro, R ;
Perticone, F ;
Sesti, G .
ENDOCRINOLOGY, 2004, 145 (06) :2845-2857
[2]   Glucosamine-induced alterations of mitochondrial function in pancreatic β-cells:: possible role of protein glycosylation [J].
Anello, M ;
Spampinato, D ;
Piro, S ;
Purrello, F ;
Rabuazzo, AM .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2004, 287 (04) :E602-E608
[3]   Prolonged incubation in PUGNAc results in increased protein O-linked glycosylation and insulin resistance in rat skeletal muscle [J].
Arias, EB ;
Kim, J ;
Cartee, GD .
DIABETES, 2004, 53 (04) :921-930
[4]   Ras and Rho GTPases: A family reunion [J].
Bar-Sagi, D ;
Hall, A .
CELL, 2000, 103 (02) :227-238
[5]   Characterization of Rac and Cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases [J].
Benard, V ;
Bohl, BP ;
Bokoch, GM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (19) :13198-13204
[6]   Rho and Rac take center stage [J].
Burridge, K ;
Wennerberg, K .
CELL, 2004, 116 (02) :167-179
[7]   P38 mitogen-activated protein kinase mediates hexosamine-induced TGFβ1 mRNA expression in human mesangial cells [J].
Burt, DJ ;
Gruden, G ;
Thomas, SM ;
Tutt, P ;
Dell'Anna, C ;
Viberti, GC ;
Gnudi, L .
DIABETOLOGIA, 2003, 46 (04) :531-537
[8]   Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling pathways [J].
Campbell, M ;
Allen, WE ;
Sawyer, C ;
Vanhaesebroeck, B ;
Trimble, ER .
CIRCULATION RESEARCH, 2004, 95 (04) :380-388
[9]  
Coffer PJ, 1998, BIOCHEM J, V329, P121
[10]   Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine [J].
Comer, FI ;
Vosseller, K ;
Wells, L ;
Accavitti, MA ;
Hart, GW .
ANALYTICAL BIOCHEMISTRY, 2001, 293 (02) :169-177